Biomm SA (Brazil) Today
| BIOM3 Stock | BRL 9.10 0.31 3.53% |
Performance4 of 100
| Odds Of DistressLess than 30
|
Biomm SA is selling for under 9.10 as of the 26th of November 2024; that is 3.53% up since the beginning of the trading day. The stock's lowest day price was 8.8. Biomm SA has about a 30 percent probability of financial distress in the next few years of operation and did not have a very good performance during the last 90 trading days. Equity ratings for Biomm SA are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 27th of October 2024 and ending today, the 26th of November 2024. Click here to learn more.
It offers AFREZZA, a human insulin inhalation powder CONFORT CARE, a moisturizing foot cream GLARGILIN, a glargine insulin and HERZUMA, a trastuzumab. Biomm S.A. was founded in 2001 and is based in So Paulo, Brazil. BIOMM ON operates under Biotechnology classification in Brazil and is traded on Sao Paolo Stock Exchange. The company has 81.29 M outstanding shares. More on Biomm SA
Moving against Biomm Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Biomm Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Biomm SA's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Biomm SA or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Francisco Freitas |
| Business Concentration | Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) |
Biomm SA (BIOM3) is traded on Sao Paulo Exchange in Brazil and employs 148 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 434.89 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Biomm SA's market, we take the total number of its shares issued and multiply it by Biomm SA's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Biomm SA operates under Biotechnology sector and is part of Health Care industry. The entity has 81.29 M outstanding shares.
Biomm SA has accumulated about 30.58 M in cash with (93.78 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.36.
Check Biomm SA Probability Of Bankruptcy
Ownership AllocationBiomm SA holds a total of 81.29 Million outstanding shares. Biomm SA retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Biomm Ownership Details
Biomm SA Risk Profiles
Although Biomm SA's alpha and beta are two of the key measurements used to evaluate Biomm SA's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.46 | |||
| Semi Deviation | 2.72 | |||
| Standard Deviation | 3.58 | |||
| Variance | 12.82 |
Biomm Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Biomm SA without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run AI Portfolio Architect Now
AI Portfolio ArchitectUse AI to generate optimal portfolios and find profitable investment opportunities |
| All Next | Launch Module |
Biomm SA Corporate Directors
| Roberto Carvalho | Director | Profile | |
| Walfrido Guia | Independent Director | Profile | |
| Italo Gaetani | Director | Profile | |
| Douglas Lopes | Strategic Planning Director, PMO and Member of The Executive Board | Profile |
Additional Tools for Biomm Stock Analysis
When running Biomm SA's price analysis, check to measure Biomm SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biomm SA is operating at the current time. Most of Biomm SA's value examination focuses on studying past and present price action to predict the probability of Biomm SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biomm SA's price. Additionally, you may evaluate how the addition of Biomm SA to your portfolios can decrease your overall portfolio volatility.